Genentech debuts next iteration of its Ocrevus MS campaign, targeting GenZ and Hispanic audiences
In the newest campaign for multiple sclerosis brand Ocrevus from Roche’s Genentech, real patients celebrate “more progress” holding up the brand’s now-familiar two-finger peace sign …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
